Capacity Expansion Laurus is expanding its manufacturing footprint in Visakhapatnam and Anakapalli with a large-scale facility and a joint venture, signaling strong capacity and capability to take on new API, CDMO, and finished-goods programs for global pharma clients.

CDMO Growth A large capex program targeting CDMO services and emerging technologies such as cell and gene therapy positions Laurus to partner across development, process optimization, and scale-up for NCE programs and advanced therapies.

Nutraceutical Niche Laurus is a trusted source of specialty nutraceutical ingredients, creating opportunities to partner on ingredient supply, formulation development, and contract manufacturing for brands seeking global reach.

Global Partnerships A joint venture with KRKA d.d. and a growing international footprint provide established channels for cross-border API supply, co-development collaborations, and expanded market access.

Financial Confidence Healthy revenue and improving profitability, along with ongoing investments, indicate the company’s capacity to commit long-term contracts and scale for large customers, making them a strong partner for strategic outsourcing.